Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.70 +0.67    +5.14%
30/04 - Closed. Currency in CNY ( Disclaimer )
  • Volume: 15,015,282
  • Bid/Ask: 13.70 / 13.71
  • Day's Range: 12.93 - 13.85
Type:  Equity
Market:  China
ISIN:  CNE100002WP3 
Nanjing King-friend Bio 13.70 +0.67 +5.14%

603707 Balance Sheet

 
Assess the latest Nanjing King-friend Biochemical Pharmaceutical Co Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 603707 Annual Report data, financial summaries and charts are available for Nanjing King-friend Biochemical Pharmaceutical Co Ltd investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 7408.7 7261.6 9257.07 9321.83
Cash and Short Term Investments 2156.39 - 2419.61 2221.6
Cash - - - -
Cash & Equivalents 1419.08 - 2106.93 1751.3
Short Term Investments - - - -
Total Receivables, Net 1132.61 - 1190.09 1410.74
Accounts Receivables - Trade, Net 897.9 - 904.17 1116.98
Total Inventory 3926.24 4158.27 5526.6 5555.58
Prepaid Expenses - 11.98 - 3.68
Other Current Assets, Total 193.47 196.99 120.77 130.23
Total Assets 9635.05 9524.26 11122.72 11095.25
Property/Plant/Equipment, Total - Net 1210.45 1235.45 1212.51 1234.6
Property/Plant/Equipment, Total - Gross - 1859.22 - 1791.85
Accumulated Depreciation, Total - -623.77 - -557.25
Goodwill, Net 127.83 - 129.36 130.18
Intangibles, Net 163.51 174.1 117.67 118.37
Long Term Investments 72.57 - 68.37 67.03
Note Receivable - Long Term 234.7 - 285.92 293.76
Other Long Term Assets, Total 33.02 - 19.47 10.72
Other Assets, Total 4343.38 4677.32 5088.24 4957.88
Total Current Liabilities 3017.76 3086.26 3654.47 3340.93
Accounts Payable 524.3 - 610.95 605.19
Payable/Accrued - - - -
Accrued Expenses 118.31 294.85 81.32 79.31
Notes Payable/Short Term Debt 1693.09 - 2254.62 2251.79
Current Port. of LT Debt/Capital Leases 507.28 5.02 500.39 0.386
Other Current liabilities, Total 174.79 681.85 207.19 404.25
Total Liabilities 3656.49 3725.77 4295.93 4482.61
Total Long Term Debt - 525.6 522.95 1020.5
Long Term Debt - 512.37 508.77 999.3
Capital Lease Obligations 12.49 - 14.18 21.2
Deferred Income Tax 36.15 - 39.49 39.69
Minority Interest -3.47 - -3.44 -3.45
Other Liabilities, Total - -3560.16 -4930.5 -4925.2
Total Equity 5978.56 - 6826.79 6612.64
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1616.65 - 1616.65 1616.65
Additional Paid-In Capital 601.29 - 600.76 600.47
Retained Earnings (Accumulated Deficit) 3716.73 - 4568.29 4353.49
Treasury Stock - Common -27.75 - -27.75 -27.75
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 71.64 - 68.84 69.78
Total Liabilities & Shareholders' Equity 9635.05 9524.26 11122.72 11095.25
Total Common Shares Outstanding - - - -
Total Preferred Shares Outstanding - - - -
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

603707 Price Commentary

Write your thoughts about Nanjing King-friend Biochemical Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email